Autolus Therapeutics plc Forecast, price target & analysts
Autolus Therapeutics plc Target price 2026 - Analyst rating & recommendation
Autolus Therapeutics plc Classifications & Recommendation
Autolus Therapeutics plc Price Target
| Target Price | $9.69 |
| Price | $1.94 |
| Potential |
399.49%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Autolus Therapeutics plc 2027 .
The average Autolus Therapeutics plc target price is $9.69.
This is
399.49%
register free of charge
$11.55
495.36%
register free of charge
$5.86
201.96%
register free of charge
|
|
| A rating was issued by 16 analysts: 15 Analysts recommend Autolus Therapeutics plc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Autolus Therapeutics plc stock has an average upside potential 2027 of
399.49%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 75.39 | 149.29 |
| 644.96% | 98.02% | |
| EBITDA Margin | -345.84% | -138.16% |
| 84.98% | 60.05% |
12 Analysts have issued a sales forecast Autolus Therapeutics plc 2026 . The average Autolus Therapeutics plc sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Autolus Therapeutics plc EBITDA forecast 2026. The average Autolus Therapeutics plc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.08 | -0.81 |
| 25.58% | 25.00% | |
| P/E | negative | |
| EV/Sales | 3.89 |
11 Analysts have issued a Autolus Therapeutics plc forecast for earnings per share. The average Autolus Therapeutics plc EPS is
This results in the following potential growth metrics and future valuations:
Autolus Therapeutics plc...
Current Autolus Therapeutics plc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 14 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Apr 09 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Mar 31 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Mar 27 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 17 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Jan 12 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 14 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Apr 09 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Mar 31 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Mar 27 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 17 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Jan 12 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
